Omnicell, Inc. Earnings Recaps
Q3 2026
Oct 30, 2026
Omnicell shares rose 2.6% after the company reported Q3 revenue and non-GAAP EBITDA above the high end of its own guidance. The reaction was positive but modest, while the provided transcript excerpt offers limited detail on the outlook or the rest of the quarter’s operating trends.
Key takeaways
- Q3 revenue was **$308 million** and non-GAAP EBITDA was **$45 million**, both above the high end of previously shared guidance.
- Management said the sales pipeline grew since the prior call, including larger deals, and described leasing as an increasingly meaningful tool in competitive bids.
- The company sees medication management as a priority investment for health systems, but purchasing decisions involve broader cross-functional evaluation and long planning cycles.
- Omnicell is advancing OmniSphere, its cloud-native platform, to connect with its solutions and provide enterprise-wide visibility and workflow capabilities.
- Management emphasized operational discipline and improving P&L leverage; the excerpt does not include the detailed financial outlook.
Q1 2026
May 1, 2026
Omnicell shares surged 14.5% following first-quarter results that landed at or above the high end of prior guidance across all key metrics. The market reacted positively to accelerating momentum in core businesses, execution on reoccurring revenue growth, and notable wins with enterprise healthcare systems.
Key takeaways
- Q1 revenue reached $310 million, with non-GAAP EBITDA of $45 million and non-GAAP EPS of $0.55, all at or above prior guidance ranges.
- Management highlighted expanding recurring revenue and successful deployment of OmniSphere, its cloud-native medication management platform, as strategic growth drivers.
- The quarter featured competitive wins, including expanded adoption by the U.S. Department of Veterans Affairs and a major New York academic medical center, signaling continued customer traction.
- The newly introduced Titan XT automated dispensing system, built on the OmniSphere platform, targets enterprise-level customers seeking improved workflows and system-wide visibility.
- Management cited disciplined cost controls and progress toward larger strategic goals, while emphasizing Omnicell’s increasing role as a technology and service partner to large healthcare organizations.